SCHEMBL26622016

SCHEMBL26622016

N#Cc1cnn2c(N)c(-c3csc4ccccc34)cnc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.54
ALDH1A1 P00352 7/20 0.54
POLB P06746 2/20 0.54
RXFP1 Q9HBX9 2/20 0.54
LMNA P02545 1/20 0.54
KDR P35968 2/20 0.43
ABL1 P00519 1/20 0.43
KDM4D Q6B0I6 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HPGD P15428 2/20 0.41
CLK4 Q9HAZ1 1/20 0.41
HTT P42858 2/20 0.40
RECQL P46063 1/20 0.40
GAA P10253 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CSNK2A1 P68400 2/20 0.39
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30640478 1.00 KDM4E (0.54) KDM4EALDH1A1POLBRXFP1LMNA
SCHEMBL26621945 0.80 KDM4E (0.57) KDM4EALDH1A1POLBRXFP1LMNA
SCHEMBL4171150 0.75 KDR (0.66) ALDH1A1RXFP1LMNAKDRNPC1
SCHEMBL26621884 0.75 NPC1 (0.43) KDM4EALDH1A1RXFP1KDRNPC1
SCHEMBL30640470 0.75 NPC1 (0.43) KDM4EALDH1A1RXFP1KDRNPC1
SCHEMBL30640466 0.74 KDM4E (0.51) KDM4EALDH1A1POLBRXFP1LMNA
SCHEMBL26622008 0.74 KDM4E (0.51) KDM4EALDH1A1POLBRXFP1LMNA
SCHEMBL4168101 0.71 LCK (0.64) KDRABL1NPC1RAB9AMEN1
SCHEMBL4160576 0.70 KDR (0.52) ALDH1A1RXFP1LMNAKDRNPC1
SCHEMBL26621968 0.70 KDM4E (0.49) KDM4EALDH1A1POLBRXFP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023214325-A1 PYRAZOLOPYRIMIDINE DERIVATIVES AND USES THEREOF AS TET2 INHIBITORS NOVARTIS AG (CH) 2023-11-09 WO disclosed